PMC:7200337 / 402-681 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":70,"end":78},"obj":"Disease"},{"id":"T9","span":{"begin":81,"end":90},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"tate of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death. We also discuss the rationale and clinical outcome of current therapeutic strategies as well as prospec"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T99629","span":{"begin":32,"end":57},"obj":"http://purl.obolibrary.org/obo/GO_0002250"}],"text":"tate of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death. We also discuss the rationale and clinical outcome of current therapeutic strategies as well as prospec"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"15","span":{"begin":145,"end":147},"obj":"Gene"},{"id":"23","span":{"begin":70,"end":90},"obj":"Disease"},{"id":"24","span":{"begin":169,"end":174},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Gene:6999"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"MESH:C000657245"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tate of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death. We also discuss the rationale and clinical outcome of current therapeutic strategies as well as prospec"}